Solid biosciences to present at the jefferies london healthcare conference

Charlestown, mass., nov. 14, 2024 (globe newswire) -- solid biosciences inc. (nasdaq: sldb) (the “company” or “solid”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced that bo combo, president and ceo, and gabriel brooks, m.d., chief medical officer, will present at the jefferies london healthcare conference on wednesday, november 20, 2024, at 1:30 p.m. gmt (8:30 a.m. et).
SLDB Ratings Summary
SLDB Quant Ranking